Methicillin-resistenter Staphylococcus aureus (MRSA) - Therapie und Hygienemaßnahmen

Literatur

• 1 Calfee D P, Durbin L J, Germanson T P. et al . Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA.  Infect Control Hosp Epidemiol. 2003;  24 422-426
• 2 Dziekan G, Hahn A, Thune K. et al . Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study.  J Hosp Infect. 2000;  46 263-270
• 3 Geldner G, Ruoff M, Hoffmann H J. et al . Cost analysis concerning MRSA-infection in ICU.  Anasthesiol Intensivmed Notfallmed Schmerzther. 1999;  34 409-413
• 4 Heuck D, Nassauer A. Methicillin-resistente Staphylococcus aureus in Alten- und Pflegeheimen.  Hygiene und Medizin. 1999;  24 72-80
• 5 Loeb M, Main C, Walker-Dilks C. et al .Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization (Cochrane Review). In: The Cochrane Library, Issue 3 2004
• 6 Ringberg H, Thoren A, Lilja B. Metastatic complications of Staphylococcus aureus septicemia. To seek is to find.  Infection. 2000;  28 132-136
• 7 Rubinstein E, Cammarata S, Oliphant T. et al . Linezolid (PNU-100 766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.  Clin Infect Dis. 2001;  32 402-412
• 8 Wunderink R G, Rello J, Cammarata S K. et al . Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.  Chest. 2003;  124 1789-1797